Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06500260

CNKSR2 Natural History Study

Natural History Study of Infants and Children With CNKSR2-Associated Neurodevelopmental Disorders and Epilepsy

Status
Recruiting
Phase
Study type
Observational
Enrollment
15 (estimated)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
6 Years – 21 Years
Healthy volunteers
Not accepted

Summary

This prospective natural history study is being conducted to define the electroclinical, neurodevelopmental, and behavioral characteristics of CNKSR2 epilepsy aphasia syndrome (EAS) and intellectual disability (ID) in children aged 6 to 21 years old with CNKSR2 mutations. The data collected from this study will serve as an external control to eventual clinical trials examining precision medicine investigational therapeutics that aim to improve the seizure burden and neurodevelopmental outcomes in patients with CNKSR2 EAS/ID.

Conditions

Timeline

Start date
2022-01-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2024-07-15
Last updated
2024-07-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06500260. Inclusion in this directory is not an endorsement.

CNKSR2 Natural History Study (NCT06500260) · Clinical Trials Directory